August 2019 cover_right.jpg
 

ISSN: 2424-810X (online)

ISSN: 2382-6533 (print)

Journal abbreviation: J Clin Transl Res

Publication frequency: Bi-monthly

Article processing charges (APC): Currently free of charge

Publishing model: Open access

Established since: 2015

Calculated 2-year impact factor (2020): 3.3, unofficial, based on Google Scholar

Calculated 4-year impact factor (2020): 6.4, unofficial, based on Google Scholar

Overall rejection rate: 33%

NEWS

JCTR's statement on "paid citations" reported by Retraction Watch

At the end of September, the editorial team of JCTR in Singapore received inquiries from authors regarding cash remuneration for researchers who cite articles published in JCTR in their own papers. This practice was addressed in a recent publication on the Retraction Watch website under the title “Publisher offers cash for citations". This incident was addressed to editor-in-chief and managing editor of JCTR on October 8th. 

The editorial board of JCTR attests that none of the in-house editors and journal staff were cognizant of these practices up until October 8th. The editors and journal staff were never involved in any fashion in gaming the metrics for any purpose, and specifically for purposes of citation gauging. We strongly condemn such unethical practices and will never engage in such acts. Accordingly, JCTR will not entertain cash requests from individuals who claim to have cited our articles, nor shall we provide any payment for citations to JCTR articles. 

Key editorial staff members convened on October 10th to properly resolve this issue. We have learned that JCTR was listed as "related journal" on Innoscience website for 10 months until mid-August. These unauthorized campaign operations by Innoscience with respect to JCTR were ceased immediately. JCTR did not and will never provide financial support or any means of support to such unauthorized campaign acts. 

We would also like to clarify that our editorial decisions on submissions, selection of editorial board members, and the integrity of published articles are not affected by the commercial entities that were formerly associated with the campaign. 

Michal Heger, editor-in-chief

Journal of Clinical and Translational Research 

October 10, 2021